Looking to Partner with the World CNS Series?
Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2026 was set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before.
If you have relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your capabilities through a bespoke commercial package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the 2026 Sponsorship Prospectus
Explore the 2026 Agenda
Interactive workshops, pharma panels and case-study led presentations: hear the industries exclusive insights
Partner With Us
Position yourself alongside pioneering biopharma to centre your solutions at the heart of a booming industry
Join Pain Experts
Be part of critical conversations with expert- attendees during dedicated networking hours